Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Pak J Pharm Sci ; 33(4): 1739-1745, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-1080067

ABSTRACT

The outbreak of CoVID-19 infection rapidly increases worldwide. Most of the continents affecting from CoVID-19 and still widening its burden disease (Jones DS, 2020; Lai et al., 2020). Along with its fatality rates, CoVID-19 has caused physiological disturbances in the society and termed as "coronophobia". CoVID-19 with renal failure, severe pneumonia and respiratory syndrome patients have been reported to increase the severity of disease conditions (Sevim et al., 2020). Also, CoVID-19 with cancer patients increase the higher risk of infections. Currently, there is no vaccine or specific treatment against CoVID-19 and drug research centres continuously investigating the potential drug against CoVID-19 (Osama and Amer, 2020). For the past 20 years two major coronavirus epidemics have occurred in public includes SARS-CoV approximately 8000 cases and 800 deaths and MERS-CoV 2,500 cases and 800 deaths and these continuing sporadically (Cascella et al., 2020).


Subject(s)
COVID-19/epidemiology , Communicable Disease Control , Age Factors , COVID-19/mortality , COVID-19/prevention & control , COVID-19/transmission , Comorbidity , Humans , Infectious Disease Incubation Period , Prevalence , Public Health , SARS-CoV-2 , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL